Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Sells $1,394,981.00 in Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Myriam Curet sold 2,401 shares of the company’s stock in a transaction on Thursday, February 27th. The shares were sold at an average price of $581.00, for a total transaction of $1,394,981.00. Following the completion of the sale, the executive vice president now directly owns 353 shares in the company, valued at approximately $205,093. This represents a 87.18 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link.

Myriam Curet also recently made the following trade(s):

• On Tuesday, February 11th, Myriam Curet sold 408 shares of Intuitive Surgical stock. The shares were sold at an average price of $589.75, for a total transaction of $240,618.00.

Intuitive Surgical Stock Up 1.7 %

Shares of Intuitive Surgical stock opened at $573.15 on Friday. The company has a market cap of $204.14 billion, a PE ratio of 89.42, a price-to-earnings-growth ratio of 5.85 and a beta of 1.39. Intuitive Surgical, Inc. has a 52 week low of $364.17 and a 52 week high of $616.00. The business has a 50 day moving average price of $569.87 and a 200-day moving average price of $529.06.

Analysts Set New Price Targets

A number of equities research analysts have recently commented on the stock. Citigroup upped their price objective on shares of Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a research note on Friday, January 24th. Piper Sandler reaffirmed an “overweight” rating and issued a $670.00 price objective (up from $538.00) on shares of Intuitive Surgical in a research note on Friday, January 24th. Morgan Stanley raised shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and increased their target price for the stock from $522.00 to $650.00 in a research note on Monday, December 2nd. Raymond James raised their price target on shares of Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a report on Friday, January 24th. Finally, Truist Financial raised their price target on shares of Intuitive Surgical from $640.00 to $666.00 and gave the stock a “buy” rating in a report on Friday, January 24th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and sixteen have assigned a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $613.10.

Institutional Trading of Intuitive Surgical

Several institutional investors and hedge funds have recently modified their holdings of ISRG. Vanguard Group Inc. increased its position in shares of Intuitive Surgical by 1.1% during the fourth quarter. Vanguard Group Inc. now owns 32,212,196 shares of the medical equipment provider’s stock valued at $16,813,478,000 after acquiring an additional 360,591 shares during the last quarter. State Street Corp increased its position in shares of Intuitive Surgical by 1.4% during the third quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider’s stock valued at $7,393,673,000 after acquiring an additional 210,363 shares during the last quarter. FMR LLC increased its position in shares of Intuitive Surgical by 8.3% during the third quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock valued at $5,389,765,000 after acquiring an additional 838,793 shares during the last quarter. Geode Capital Management LLC increased its position in shares of Intuitive Surgical by 3.2% during the fourth quarter. Geode Capital Management LLC now owns 7,756,727 shares of the medical equipment provider’s stock valued at $4,039,200,000 after acquiring an additional 243,802 shares during the last quarter. Finally, Fisher Asset Management LLC increased its position in shares of Intuitive Surgical by 1.8% during the fourth quarter. Fisher Asset Management LLC now owns 4,868,869 shares of the medical equipment provider’s stock valued at $2,541,356,000 after acquiring an additional 86,488 shares during the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.